Prescient Therapeutics
About:
Prescient Therapeutics is a biopharmaceutical company, discovers and develops novel immunotherapeutic products for the treatment of chronic.
Website: https://ptxtherapeutics.com/
Twitter/X: ptx_aus
Description:
Prescient Therapeutics (PTX) is a clinical stage oncology company developing novel compounds that show great promise as potential new therapies to treat a range of solid and hematological cancers.
Total Funding Amount:
$3M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
South Melbourne, Victoria, Australia
Founded Date:
1999-01-01
Contact Email:
justin(AT)ptxtherapeutics.com
Founders:
Said Sebti
Number of Employees:
1-10
Last Funding Date:
2014-03-24
IPO Status:
Public
Industries:
© 2025 bioDAO.ai